Peter Applebaum, Ph.D.
HERSHEY MEDICAL CENTER Roger Echols, Ph.D.
Vice President, Infectious Disease Clinical Development
BRISTOL-MYERS SQUIBB John F. Barrett
Director, Anti-Infectives
MERCK & CO. William R. Jacobs, Jr., Ph.D.
Professor, Albert Einstein College of Medicine Jeffery Stein, Ph.D.
Senior Staff Investigator
Vertex Pharmaceuticals Yat Sun Or, Ph.D.
Senior Vice President, R&D
Enanta Pharmaceuticals Jeffery H. Toney, Ph.D
Department of Chemistry & Biochemistry
Montclair State University Stephen Hawser, Ph.D.
Director of Biology
ARPIDA AG Hand-Henrik Kristensen Hoegenhaug, Ph.D.
Manager, Protein Design
NOVOZYMES A/S Joyce Sutcliffe, Ph.D.
Vice President, Biochemistry & Molecular Biology
RIB-X Pharmaceuticals Thomas Hermann, Ph.D.
Principal Scientist
ANADYS Malcolm G. P. Page, Ph.D.
Head of Biology
Basilea Pharmaceutica Steven L. Barriere, Ph.D.
Senior Director Clinical Research
THERAVANCE Jeff Alder, Ph.D.
Senior Director Drug Evaluation
Cubist Pharmaceuticals Jeffery S. Loutit, M.D.
Senoir Director, Clinical Research
INTERMUNE Daniel Sahm, Ph.D.
Cheif Scientific Officer
Focus Technologies Zehngyu Yuan, Ph.D.
VP Discovery Pharmacology
Vicuron Pharmaceuticals Kirk Johnson, Ph.D.
Pharmacology & Preclinical Development
Genesoft Pharmaceuticals Jinzi Wu, Ph.D.
VP Research
PHAGETECH
|